Literature DB >> 26416775

Giant cell arteritis: a closer look at its ophthalmological manifestations.

Nuno G Pinto Ferreira1, Luiz Menezes Falcão2, Antonio T Alves3, Fatima Campos1.   

Abstract

Giant cell arteritis with ocular involvement is an ocular emergency. Arteritic anterior ischaemic optic neuropathy (AAION) is the most common ophthalmological manifestation associated with this disease. Visual loss is usually permanent with rare cases showing visual recovery. Visual improvement, if it occurs, is generally limited, and the visual field defects are persistent and severe. The main goal of AAION treatment is the preservation of vision in the fellow eye. In patients with neurophthalmological manifestations, high-dose corticosteroids should be initiated immediately and aggressively, and maintained thereafter. We present a case of AAION and severe vision loss where significant visual recovery was seen after treatment. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26416775      PMCID: PMC4593263          DOI: 10.1136/bcr-2015-210995

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Role of ultrasonography in the diagnosis of temporal arteritis.

Authors:  E L Ball; S R Walsh; T Y Tang; R Gohil; J M F Clarke
Journal:  Br J Surg       Date:  2010-12       Impact factor: 6.939

Review 2.  Giant cell arteritis.

Authors:  Helen V Danesh-Meyer; Peter J Savino
Journal:  Curr Opin Ophthalmol       Date:  2007-11       Impact factor: 3.761

Review 3.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

4.  Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients.

Authors:  Miguel A Gonzalez-Gay; Maria J Lopez-Diaz; Sonia Barros; Carlos Garcia-Porrua; Amalia Sanchez-Andrade; Jose Paz-Carreira; Javier Martin; Javier Llorca
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

5.  Poor prognosis of visual outcome after visual loss from giant cell arteritis.

Authors:  Helen Danesh-Meyer; Peter J Savino; Greg G Gamble
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

6.  The importance of skip lesions in temporal arteritis.

Authors:  D N Poller; Q van Wyk; M J Jeffrey
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

7.  Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

Authors:  Alfred D Mahr; Juan A Jover; Robert F Spiera; César Hernández-García; Benjamin Fernández-Gutiérrez; Michael P Lavalley; Peter A Merkel
Journal:  Arthritis Rheum       Date:  2007-08

8.  Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Ophthalmologica       Date:  2003 Jul-Aug       Impact factor: 3.250

  8 in total
  1 in total

1.  Combined Left Central Retinal Artery Occlusion and Bilateral Anterior Ischemic Optic Neuritis: A Rare Presentation of Giant Cell Arteritis.

Authors:  Anne D D Joseph; Jebananthy Anandaselvam Pradeepan; Thirunavukarasu Kumanan; Muthusamy Malaravan
Journal:  Case Rep Rheumatol       Date:  2019-09-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.